CXCL10 and rheumatoid arthritis: A significant difference was observed in CXCL-10 levels between RA-ILD and RA patients (MD = 141.09; 95% CI: 81.24-200.94; P < 0.001), with low heterogeneity (I2 = 0.00%, P = 0.58).